De Novo Drug Design of Potential Inhibitors of SARS-CoV-2 Papain-like Protease

Ítems similars

• De Novo Drug Design of Potential Inhibitors of the Receptor-Binding Domain of SARS-CoV-2 Variants
  per: Edgar Clyde R. Lopez
  Publicat: (2023-04-01)
• Repurposing Known Drugs as Covalent and Non-covalent Inhibitors of the SARS-CoV-2 Papain-Like Protease
  per: Pietro Delre, et al.
  Publicat: (2020-11-01)
• Molecular Docking Study of Nigella sativa Alkaloid Compounds as the Inhibitor of Papain-Like Protease SARS-CoV-2
  per: Gusnia Meilin Gholam, et al.
  Publicat: (2023-06-01)
• Identification of SARS‐CoV‐2 Papain‐like Protease (PLpro) Inhibitors Using Combined Computational Approach**
  per: Dr. Milan Sencanski, et al.
  Publicat: (2022-02-01)
• Hemi-Babim and Fenoterol as Potential Inhibitors of MPro and Papain-like Protease against SARS-CoV-2: An In-Silico Study
  per: Ahmad Alzamami, et al.
  Publicat: (2022-04-01)